SCHEMBL7464659

SCHEMBL7464659

CCCNc1ncccc1Br

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 1/20 0.55
HPGD P15428 1/20 0.55
HSD17B10 Q99714 1/20 0.55
UTS2R Q9UKP6 3/20 0.44
HTT P42858 2/20 0.44
CCNC P24863 1/20 0.44
CDK8 P49336 1/20 0.44
TLR7 Q9NYK1 2/20 0.40
TLR8 Q9NR97 1/20 0.40
APP P05067 1/20 0.38
LATS1 O95835 3/20 0.38
LATS2 Q9NRM7 2/20 0.38
PDE5A O76074 2/20 0.38
SYK P43405 1/20 0.37
FDPS P14324 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
KCNH2 Q12809 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7479010 0.89 TLR8 (0.51) ALDH1A1KDM4EHPGDHSD17B10UTS2R
SCHEMBL11666495 0.88 UTS2R (0.48) ALDH1A1KDM4EHPGDHSD17B10UTS2R
SCHEMBL7468377 0.85 GRM5 (0.43) ALDH1A1KDM4EHPGDHSD17B10UTS2R
SCHEMBL29882733 0.81 KDM4E (0.47) ALDH1A1KDM4EHPGDHSD17B10HTT
SCHEMBL18356238 0.81 KDM4E (0.47) ALDH1A1KDM4EHPGDHSD17B10HTT
SCHEMBL13931357 0.81 SYK (0.46) ALDH1A1KDM4EHPGDHSD17B10SYK
SCHEMBL7470851 0.81 CYP2C19 (0.54) SYK
SCHEMBL1255125 0.81 UTS2R (0.48) ALDH1A1KDM4EHSD17B10UTS2RHTT
SCHEMBL6442879 0.79 KDM4E (0.57) ALDH1A1KDM4EHPGDHSD17B10UTS2R
SCHEMBL1977303 0.79 KDM4E (0.57) ALDH1A1KDM4EHPGDHSD17B10UTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022086920-A1 GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE (QPCTL) PROTEIN INHIBITORS AND USES THEREOF BLACKSMITH MEDICINES, INC. (US) 2022-04-28 WO disclosed
EP-0963986-B1 5,10-Dihydrodipyrido(2,3-b:2,3-e)pyrazine and 5,10-dihydro(2,3-b:3,2-e)pyrazine, process for their preparation and pharmaceutical compositions containing them SERVIER LAB (FR) 2002-04-17 EP disclosed
US-6127369-A 5,10-dihydrodipyrido[2,3-b:2,3-e]pyrazin and 5,10-dihydrodipyrido[2,3-b:3,2-e]pyrazin compounds ADIR ET COMPAGNIE (FR) 2000-10-03 US disclosed
EP-0963986-A2 5,10-Dihydrodipyrido(2,3-b:2,3-e)pyrazine and 5,10-dihydro(2,3-b:3,2-e)pyrazine, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1999-12-15 EP disclosed